基于18F-FDG PET-CT的类风湿关节炎关节计数与疾病活动度评估工具的开发与验证
本研究纳入91例活动性类风湿关节炎(RA)患者,开发组69例、验证组22例,同期行18F-FDG PET-CT与临床疾病活动度评估。PET阳性关节数与肿胀关节数、压痛关节数及DAS28-ESR显著相关,并据此构建PET/DAS;验证组中PET/DAS与DAS28-ESR显著相关(P < 0.001)。
要点
- PET阳性关节数与SJC、TJC及DAS28-ESR显著相关。
- PET/DAS在独立验证组中与DAS28-ESR显著相关(P < 0.001)。
- PET-CT可作为评估RA疾病活动度的敏感可靠方法,适用于临床研究。
核心结论
- PET-CT可作为评估RA患者疾病活动度的敏感且可靠的方法,尤其可作为临床研究工具。
研究设计与样本
- 研究纳入91例活动性RA患者,其中开发组69例、验证组22例,均同期接受18F-FDG PET-CT与临床疾病活动度评估。
主要发现
- 28关节和68关节的PET阳性关节数与肿胀关节数(SJC)、压痛关节数(TJC)及DAS28-ESR显著相关。
- PET评估受累关节计数的观察者内和观察者间可靠性均优良;核医学医师与风湿科医师之间对28关节和68关节SJC及TJC的观察者间可靠性良好。
- 多因素分析纳入ESR和患者总体疾病活动度评估(PtGA)后,PET/DAS推导为(0.063 × 28关节PET阳性关节数)+(0.011 × ESR)+(0.030 × PtGA)。
- 验证组中PET/DAS与DAS28-ESR显著相关(P < 0.001)。
关键数值与推荐
- PET/DAS计算公式为(0.063 × 28关节PET阳性关节数)+(0.011 × ESR)+(0.030 × PtGA)。
临床怎么用
- 在临床研究中,可考虑采用PET-CT评估RA关节受累及疾病活动度,尤其适用于临床试验场景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Clinical joint count assessment is important for detecting synovitis but its reliability is a subject of controversy. This study was undertaken to assess the correlation of positron emission tomography (PET)-derived parameters in 68 joints with disease activity and to compare the reliability of joint counts between PET with computed tomography (CT) and clinical assessment in patients with rheumatoid arthritis (RA). METHODS: We enrolled 91 patients with active RA (69 in a development group and 22 in a validation group) who underwent concurrent 18 F-fluorodeoxyglucose (18 F-FDG)-PET-CT and clinical disease activity evaluation. PET-derived parameters were compared with disease activity assessed using clinical joint count parameters. A Disease Activity Score (DAS) using counts of PET-positive joints was developed, and then validation studies were performed in an independent group. RESULTS: The number of PET-positive joints (of 28 and 68 joints) was significantly correlated with the swollen joint count (SJC) and tender joint count (TJC) and the DAS in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR). Intraobserver and interobserver reliability of PET for the affected joint counts were excellent. Interobserver reliability between nuclear medicine physicians and rheumatologists was good for the SJC and TJC in both 28 joints and 68 joints. After multivariate analyses, including ESR and patient's global assessment of disease activity (PtGA) in addition to PET-derived parameters, the PET/DAS was derived as (0.063 × number of PET-positive joints in 28 joints) + (0.011 × ESR) + (0.030 × PtGA). A significant correlation between the PET/DAS and the DAS28-ESR was confirmed in the validation group (P < 0.001). CONCLUSION: PET-CT could serve as a sensitive and reliable method in the evaluation of disease activity in RA patients, and may be applicable as a research tool, particularly in clinical trials.
引用
- Lee SJ, Jeong JH, Lee CH, et al. Development and Validation of an 18 F-Fluorodeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Tool for the Evaluation of Joint Counts and Disease Activity in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2019. PMID: 30771237. doi:10.1002/art.40860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。